Trials / Completed
CompletedNCT00394537
Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Passing a bronchoscope through the airways frequently causes a stress response even though patients are sedated. This stress response is usually an increase in pulse and blood pressure, which may have undesirable effects on the heart and circulation. We plan to give patients labetalol (a beta blocker which reduces pulse and blood pressure) in addition to normal sedation, to patients undergoing bronchoscopy in our department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Labetalol 10mg iv |
Timeline
- Completion
- 2007-05-01
- First posted
- 2006-11-01
- Last updated
- 2007-06-06
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00394537. Inclusion in this directory is not an endorsement.